175 related articles for article (PubMed ID: 10763860)
1. Modulation of cross-bridge interaction by 2,3-butanedione monoxime in human ventricular myocardium.
Brixius K; Schwinger RH
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):440-4. PubMed ID: 10763860
[TBL] [Abstract][Full Text] [Related]
2. Reduced length-dependent cross-bridge recruitment in skinned fiber preparations of human failing myocardium.
Brixius K; Savidou-Zaroti P; Bloch W; Schwinger RH
Eur J Appl Physiol; 2003 May; 89(3-4):249-56. PubMed ID: 12736832
[TBL] [Abstract][Full Text] [Related]
3. Different effect of the Ca(2+) sensitizers EMD 57033 and CGP 48506 on cross-bridge cycling in human myocardium.
Brixius K; Mehlhorn U; Bloch W; Schwinger RH
J Pharmacol Exp Ther; 2000 Dec; 295(3):1284-90. PubMed ID: 11082466
[TBL] [Abstract][Full Text] [Related]
4. Effects of 2,3-butanedione monoxime on cross-bridge kinetics in rat cardiac muscle.
Ebus JP; Stienen GJ
Pflugers Arch; 1996 Sep; 432(5):921-9. PubMed ID: 8772144
[TBL] [Abstract][Full Text] [Related]
5. Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
Schwinger RH; Böhm M; Koch A; Morano I; Rüegg JC; Erdmann E
J Pharmacol Exp Ther; 1994 May; 269(2):778-86. PubMed ID: 8182546
[TBL] [Abstract][Full Text] [Related]
6. Cellular basis of negative inotropic effect of 2,3-butanedione monoxime in human myocardium.
Perreault CL; Mulieri LA; Alpert NR; Ransil BJ; Allen PD; Morgan JP
Am J Physiol; 1992 Aug; 263(2 Pt 2):H503-10. PubMed ID: 1510147
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of force inhibition by 2,3-butanedione monoxime in rat cardiac muscle: roles of [Ca2+]i and cross-bridge kinetics.
Backx PH; Gao WD; Azan-Backx MD; Marban E
J Physiol; 1994 May; 476(3):487-500. PubMed ID: 8057256
[TBL] [Abstract][Full Text] [Related]
8. Contractile deactivation and uncoupling of crossbridges. Effects of 2,3-butanedione monoxime on mammalian myocardium.
Gwathmey JK; Hajjar RJ; Solaro RJ
Circ Res; 1991 Nov; 69(5):1280-92. PubMed ID: 1934358
[TBL] [Abstract][Full Text] [Related]
9. Reversible desensitization of the myocardial contractile apparatus for calcium. A new concept for improving tolerance to cold ischemia in human myocardium?
Vahl CF; Bonz A; Hagl C; Hagl S
Eur J Cardiothorac Surg; 1994; 8(7):370-8. PubMed ID: 7946415
[TBL] [Abstract][Full Text] [Related]
10. BDM compared with P(i) and low Ca2+ in the cross-bridge reaction initiated by flash photolysis of caged ATP.
Kagawa K; Horiuti K; Yamada K
Biophys J; 1995 Dec; 69(6):2590-600. PubMed ID: 8599666
[TBL] [Abstract][Full Text] [Related]
11. Effects of 2,3-butanedione monoxime on sarcoplasmic reticulum of saponin-treated rat cardiac muscle.
Steele DS; Smith GL
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1493-500. PubMed ID: 8238560
[TBL] [Abstract][Full Text] [Related]
12. The effect of 2,3-butanedione 2-monoxime (BDM) on ventricular trabeculae from the avian heart.
Brotto MA; Fogaça RT; Creazzo TL; Godt RE; Nosek TM
J Muscle Res Cell Motil; 1995 Feb; 16(1):1-10. PubMed ID: 7751400
[TBL] [Abstract][Full Text] [Related]
13. "Cardioplegia on the contractile apparatus level": evaluation of a new concept for myocardial preservation in perfused pig hearts.
Vahl CF; Bonz A; Hagl C; Timek T; Herold U; Fuchs H; Kochsiek N; Hagl S
Thorac Cardiovasc Surg; 1995 Aug; 43(4):185-93. PubMed ID: 7502280
[TBL] [Abstract][Full Text] [Related]
14. The influence of 2,3-butanedione 2-monoxime (BDM) on the interaction between actin and myosin in solution and in skinned muscle fibres.
McKillop DF; Fortune NS; Ranatunga KW; Geeves MA
J Muscle Res Cell Motil; 1994 Jun; 15(3):309-18. PubMed ID: 7929796
[TBL] [Abstract][Full Text] [Related]
15. Effect of 2,3-butanedione monoxime on myocyte resting force during prolonged metabolic inhibition.
Ikenouchi H; Zhao L; Barry WH
Am J Physiol; 1994 Aug; 267(2 Pt 2):H419-30. PubMed ID: 8067394
[TBL] [Abstract][Full Text] [Related]
16. Interplay of troponin- and Myosin-based pathways of calcium activation in skeletal and cardiac muscle: the use of W7 as an inhibitor of thin filament activation.
Adhikari BB; Wang K
Biophys J; 2004 Jan; 86(1 Pt 1):359-70. PubMed ID: 14695278
[TBL] [Abstract][Full Text] [Related]
17. Muscle cross-bridges bound to actin are disordered in the presence of 2,3-butanedione monoxime.
Zhao L; Naber N; Cooke R
Biophys J; 1995 May; 68(5):1980-90. PubMed ID: 7612840
[TBL] [Abstract][Full Text] [Related]
18. Skinned cardiac fibres of diabetic rats: contractile activation and effects of 2,3-butanedione monoxime (BDM) and caffeine.
Khandoudi N; Guo AC; Chesnais M; Feuvray D
Cardiovasc Res; 1993 Mar; 27(3):447-52. PubMed ID: 8490945
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of 2,3-butanedione monoxime on contracture during metabolic inhibition.
Hajjar RJ; Ingwall JS; Gwathmey JK
Am J Physiol; 1994 Jul; 267(1 Pt 2):H100-8. PubMed ID: 8048573
[TBL] [Abstract][Full Text] [Related]
20. Contractile activation and measurements of intracellular Ca2+ concentration in cane toad twitch fibres in the presence of 2,3-butanedione monoxime.
Lyster DJ; Stephenson DG
Exp Physiol; 1995 Jul; 80(4):543-60. PubMed ID: 7576595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
